Posts by John

Piramal Pharma shares jumped 4% following a successful US FDA inspection. Learn how this regulatory milestone bolsters the company's global growth outlook.

Discover how Real-World Evidence is reshaping clinical trials and accelerating drug development by using patient data from outside traditional study settings.

AstraZeneca stock falls following a clinical trial failure. Get the latest analysis on the impact of this study and the firm’s future research outlook.

AstraZeneca shares dropped 9% after a key heart drug trial failed. Read our analysis on the clinical impact and what this means for the company's future.

New trial data shows SAT-3247 reduces muscle fat infiltration in adults with Duchenne muscular dystrophy, offering a potential breakthrough in muscle repair.

New phase 3 data shows setmelanotide effectively treats hypothalamic obesity by targeting MC4R signaling. Discover the potential breakthrough in weight loss.

Can a vaccine stop opioid overdoses? Explore the latest science behind fentanyl immunization and the complex clinical challenges facing researchers today.

A new study explores the performance of Nanox's AI solution in cardiac imaging, aiming to enhance diagnostic speed and accuracy in cardiovascular care.

Explore how a unique Delhi puppet show is blending traditional performance art with the complexities of DNA and genetics to spark new scientific interest.

A breakthrough clinical trial offers new hope for babies with fetal kidney failure, potentially transforming the prognosis for congenital renal conditions.